Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy

Despite a generally better prognosis than high-grade glioma (HGG), recurrence and malignant progression are the main causes for the poor prognosis and difficulties in the treatment of low-grade glioma (LGG). It is of great importance to learn about the risk factors and underlying mechanisms of LGG r...

Descripción completa

Detalles Bibliográficos
Autores principales: Teng, Chubei, Zhu, Yongwei, Li, Yueshuo, Dai, Luohuan, Pan, Zhouyang, Wanggou, Siyi, Li, Xuejun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168984/
https://www.ncbi.nlm.nih.gov/pubmed/35677036
http://dx.doi.org/10.3389/fimmu.2022.899710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168984/
https://www.ncbi.nlm.nih.gov/pubmed/35677036
http://dx.doi.org/10.3389/fimmu.2022.899710

Ejemplares similares